*Warren Alpert Medical School of Brown University †Department of Ecology and Evolutionary Biology, Brown University ‡Center for Sexuality, Intimacy, and Fertility, Women & Infants' Hospital, Providence, RI §Southern California Center for Sexual Health and Survivorship Medicine, Newport Beach, CA.
Am J Clin Oncol. 2014 Feb;37(1):101-6. doi: 10.1097/COC.0b013e318248d89d.
Cancer survivors face a myriad of long-term effects of their disease, diagnosis, and treatment, and chief among many are problems associated with sexual dysfunction. Yet despite their frequency and the degree of distress they cause patients, sexual dysfunction is not effectively screened for or treated, and this is particularly true in female survivors. Inconsistently performed general sexual health screening at all facets of cancer care and survivorship ultimately translates into missed attempts to identify and treat dysfunction when it does arise. In this paper, we will review the current research and clinical practices addressing sexual dysfunction in female cancer survivors and propose questions in need of future research attention. This article will review the phases of sexual response and how each may be affected by the physical and emotional stress of cancer diagnosis and treatment. We will then discuss existing tools for assessment of sexual function and approaches to their treatment. Finally, we will conclude with advice to health care professionals based on current research and suggest questions for future study.
癌症幸存者面临着疾病、诊断和治疗带来的诸多长期影响,其中最主要的是与性功能障碍相关的问题。然而,尽管这些问题非常普遍,而且给患者带来了极大的困扰,但性功能障碍并没有得到有效的筛查或治疗,尤其是在女性幸存者中。在癌症治疗和康复的各个阶段,不规范的全面性功能健康筛查最终导致了在出现性功能障碍时无法识别和治疗。在本文中,我们将回顾目前针对女性癌症幸存者性功能障碍的研究和临床实践,并提出未来需要关注的研究问题。本文将回顾性反应的各个阶段,以及每个阶段如何受到癌症诊断和治疗的身体和情绪压力的影响。然后,我们将讨论现有的性功能评估工具及其治疗方法。最后,我们将根据当前的研究为医疗保健专业人员提供建议,并提出未来研究的问题。